We are live on ! Find out more
APP

Avantax Planning Partners Portfolio holdings

AUM $4.02B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+20%
3 Year Est. Return
+51.05%
5 Year Est. Return
+51.22%
10 Year Est. Return
AUM
$1.63B
AUM Growth
+$82.8M
Cap. Flow
+$77.5M
Cap. Flow %
4.76%
Top 10 Hldgs %
77.41%
Holding
313
New
14
Increased
150
Reduced
89
Closed
8
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOG icon
126
Alphabet (Google) Class C
GOOG
$4.36T
$809K 0.05%
13,280
+180
+1% +$10.7K
HON icon
127
Honeywell
HON
$77B
$804K 0.05%
5,039
+330
+7% +$52.5K
LOW icon
128
Lowe's Companies
LOW
$117B
$804K 0.05%
7,314
+145
+2% +$15.3K
EFG icon
129
iShares MSCI EAFE Growth ETF
EFG
$16.6B
$797K 0.05%
9,903
COP icon
130
ConocoPhillips
COP
$147B
$796K 0.05%
13,962
-315
-2% -$17.9K
MDT icon
131
Medtronic
MDT
$109B
$769K 0.05%
7,076
+2,185
+45% +$228K
MCHP icon
132
Microchip Technology
MCHP
$40.3B
$748K 0.05%
16,108
-870
-5% -$39.5K
ORCL icon
133
Oracle
ORCL
$374B
$738K 0.05%
13,409
-3,158
-19% -$174K
IVV icon
134
iShares Core S&P 500 ETF
IVV
$878B
$724K 0.04%
2,425
+365
+18% +$108K
SBUX icon
135
Starbucks
SBUX
$120B
$720K 0.04%
8,141
-579
-7% -$53.7K
MA icon
136
Mastercard
MA
$502B
$698K 0.04%
2,571
+7
+0.3% +$1.93K
NUMV icon
137
Nuveen ESG Mid-Cap Value ETF
NUMV
$444M
$673K 0.04%
23,167
+405
+2% +$11.5K
VWO icon
138
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$673K 0.04%
16,709
+1,376
+9% +$56.8K
CL icon
139
Colgate-Palmolive
CL
$73.1B
$671K 0.04%
9,132
+3,630
+66% +$263K
CVS icon
140
CVS Health
CVS
$133B
$663K 0.04%
10,515
+164
+2% +$9.72K
NFLX icon
141
Netflix
NFLX
$299B
$644K 0.04%
24,070
-460
-2% -$14.4K
ADBE icon
142
Adobe
ADBE
$99.5B
$642K 0.04%
2,324
+342
+17% +$99.8K
GILD icon
143
Gilead Sciences
GILD
$162B
$640K 0.04%
10,104
+339
+3% +$22.2K
IJH icon
144
iShares Core S&P Mid-Cap ETF
IJH
$122B
$633K 0.04%
16,375
+1,475
+10% +$56.7K
CRM icon
145
Salesforce
CRM
$151B
$625K 0.04%
4,210
+596
+16% +$90.6K
MDLZ icon
146
Mondelez International
MDLZ
$79.5B
$610K 0.04%
11,027
+122
+1% +$6.67K
CLX icon
147
Clorox
CLX
$11.6B
$607K 0.04%
3,994
MCK icon
148
McKesson
MCK
$100B
$601K 0.04%
4,395
+125
+3% +$17.7K
LLY icon
149
Eli Lilly
LLY
$1.02T
$584K 0.04%
5,222
-1,386
-21% -$154K
AEP icon
150
American Electric Power
AEP
$69.6B
$580K 0.04%
6,191
+3
+0% +$272

Similar funds

Avantax Planning Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Avantax Planning Partners held 313 positions worth $1.63B, up 5.4% from $1.55B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Avantax Planning Partners deployed $77.5M of net new capital in Q3 2019, opening 14 new positions and adding to 150 existing holdings. Its largest new stake was SPDR Gold Trust: 3,722 shares worth $517K.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 400 Mid Cap Growth ETF, an estimated $32.3M trimmed.

  • Avantax Planning Partners's largest Q3 2019 buy was SPDR Gold Trust: 3,722 shares worth $517K.
  • Avantax Planning Partners added most to Schwab US Large-Cap Value ETF in Q3 2019, an estimated $127M increase.
  • Avantax Planning Partners's biggest Q3 2019 reduction was State Street SPDR S&P 400 Mid Cap Growth ETF, cutting an estimated $32.3M.
  • Avantax Planning Partners fully exited Array Biopharma Inc in Q3 2019, selling an estimated $297K.
  • Avantax Planning Partners's ten largest holdings make up 77% of its $1.63B portfolio in Q3 2019.
  • Avantax Planning Partners opened 14 new positions and closed 8 in Q3 2019.
  • Avantax Planning Partners's portfolio value rose 5.4% quarter-over-quarter to $1.63B.

Based on Avantax Planning Partners's 13F filing for Q3 2019, filed 8 Nov 2019.